Abstract
Colorectal cancer is one of the most common malignant tumors, early diagnosis and treatment are the important factors affecting colorectal cancer′s prognosis. It has been proved that colorectal cancer′s diagnosis combined with biomolecular markers is non-invasive, economical and specific at the same time, biomarkers are valuable in predicting and monitoring the chemoresistance of colorectal cancer. This article mainly reviews the prediction of liver metastasis of colorectal cancer, drug resistance of postoperative chemotherapy in colorectal cancer and the monitoring of drug resistance in the course of chemotherapy by CD44v6. Key words: Colorectal neoplasms; Drug therapy, combination; Drug resistance, neoplasms; CD44v6
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call